Peroxisome Proliferator-Activated Receptor-γ Ligands: Potential Pharmacological Agents for Targeting the Angiogenesis Signaling Cascade in Cancer
2008
PPAR-γ Ligands: Potential Cancer Treatment
publication
Evidence: moderate
Author Information
Author(s): Giaginis Costas, Tsantili-Kakoulidou Anna, Theocharis Stamatios
Primary Institution: University of Athens
Hypothesis
Can PPAR-γ ligands effectively target angiogenesis in cancer treatment?
Conclusion
PPAR-γ ligands can inhibit angiogenesis and may serve as potential therapeutic agents in cancer treatment.
Supporting Evidence
- PPAR-γ ligands can inhibit cell growth and induce apoptosis in various cancer types.
- Targeting PPAR-γ may enhance the effectiveness of conventional chemotherapy.
- PPAR-γ ligands can modulate the balance between angiogenic and antiangiogenic factors.
Takeaway
PPAR-γ ligands are like special medicines that can help stop cancer from growing by blocking the blood vessels it needs.
Methodology
The review summarizes experimental data from in vitro cultures, animal models, and clinical trials regarding the effects of PPAR-γ ligands on angiogenesis.
Limitations
The review highlights the complexity of PPAR-γ ligands' effects, which can vary based on concentration and context.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website